Related references
Note: Only part of the references are listed.Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy
Wen Wee Ma
Anti-Cancer Agents in Medicinal Chemistry (2012)
Expression of focal adhesion kinase in small-cell lung carcinoma
Sebahat Ocak et al.
CANCER (2012)
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
Kelli Bullard Dunn et al.
Anti-Cancer Agents in Medicinal Chemistry (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAX and IGF-IR in vitro and in vivo
Naito Kurio et al.
EXPERIMENTAL CELL RESEARCH (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models
Colin Walsh et al.
CANCER BIOLOGY & THERAPY (2010)
A PAK-Activated Linker for EGFR and FAK
Alok Tomar et al.
DEVELOPMENTAL CELL (2010)
Targeting focal adhesion kinase signaling in tumor growth and metastasis
Joerg Schwock et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
The FERM domain: organizing the structure and function of FAK
Margaret C. Frame et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway
S. Ocak et al.
ONCOGENE (2010)
Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
X. N. Meng et al.
BRITISH JOURNAL OF CANCER (2009)
FAK overexpression and p53 mutations are highly correlated in human breast cancer
Vita M. Golubovskaya et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
Tsukasa Shibue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The role of focal adhesion kinase in tumor initiation and progression
Paolo P. Provenzano et al.
CELL ADHESION & MIGRATION (2009)
Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271
Walter Gregory Roberts et al.
CANCER RESEARCH (2008)
The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer A Literature Review
Fred R. Hirsch et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Metastasis: a therapeutic target for cancer
Patricia S. Steeg et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Cellular characterization of a novel focal adhesion kinase inhibitor
Jill K. Slack-Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Up-regulation of focal adhesion kinase in non-small cell lung cancer
Stephana Carelli et al.
LUNG CANCER (2006)
Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells
CA Garces et al.
CANCER RESEARCH (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
N Benlimame et al.
JOURNAL OF CELL BIOLOGY (2005)
The role of focal-adhesion kinase in cancer. A ew therapeutic opportunity
GW McLean et al.
NATURE REVIEWS CANCER (2005)
Focal adhesion kinase: In command and control of cell motility
SK Mitra et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly
DJ Webb et al.
NATURE CELL BIOLOGY (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Prognostic factors in non-small cell lung cancer - A decade of progress
MD Brundage et al.
CHEST (2002)
FAK integrates growth-factor and integrin signals to promote cell migration
DJ Sieg et al.
NATURE CELL BIOLOGY (2000)
Share Paper
